An at-risk group indicates the possibility that the disease may be associated with the risk of vital nutrient deficiency. The complaint diabetic polyneuropathy indicates a vital nutrient deficiency for
- L-carnitine
Within the framework of micronutrient medicine, the following vital substances (micronutrients) are used for prevention.
- Omega-6 fatty acid gamma-linolenic acid
Within the framework of micronutrient medicine, the following vital substances (micronutrients) are used for supportive therapy.
- Vitamin B12
- Zinc
- Omega-6 fatty acid gamma-linolenic acid
- Alpha lipoic acid